Sun Jin Sym - Concepedia

Author

Sun Jin Sym

Gachon University Gil Medical Center ORCID

Also Known As

Bruno Vincenzi, Igor Yurievich Kudryavtsev, Jungil Choi, S. Sym, S.J. Sym, Sun J Sym, Sun Jin Sym, Sun jin Sym

154

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Gachon University Gil Medical Center Ulsan College University of Ulsan Asan Medical Center Gachon University

About

Sun Jin Sym is an author at Gachon University Gil Medical Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	30	1.4K
2	Health Sciences	5	5	192
3	Public Health	1	1	12
4	Blood Transplantation	1	1	36
5	Cell Biology	1	1	31

Sun Jin Sym

Publications

Citations

H-Index

Page 1

	Year	Citations
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial Yoon‐Koo Kang, Li‐Tzong Chen, Min‐Hee Ryu, The Lancet Oncology	2022	712
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial Daniel V.T. Catenacci, Yoon‐Koo Kang, Haeseong Park, The Lancet Oncology OncologyEsophageal CancerGastrointestinal OncologyPathologyImmune Checkpoint Inhibitor	2020	186
A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer Hee Kyung Ahn, Minkyu Jung, Sun Jin Sym, Cancer Chemotherapy and Pharmacology	2014	174
Brain metastases in breast cancer: prognostic factors and management Sung Sook Lee, Jin‐Hee Ahn, Min Kyoung Kim, Breast Cancer Research and Treatment Neuro-oncologyBreast OncologyBrain MetastasesMedicineCancer Management	2007	156
LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study Narikazu Boku, M.-H. Ryu, D-Y. Oh, Annals of Oncology Chemotherapy Versus ChemotherapyGastrointestinal OncologyMedicineGastroenterologyPathology	2020	123
Intramedullary spinal cord metastases: a single-institution experience Sung Sook Lee, Min Kyoung Kim, Sun Jin Sym, Journal of Neuro-Oncology Neuro-oncologySurgical OncologySpinal Cord InjurySingle-institution ExperienceMedicine	2007	108
BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin’s lymphoma patients: comparative analysis of efficacy and toxicity Jae‐Cheol Jo, Byung Wook Kang, Geundoo Jang, Annals of Hematology Lymphoid NeoplasiaCell TherapyTransplantationMarrow TransplantationMedicine	2007	85
A randomized phase II study of biweekly irinotecan monotherapy or a combination of irinotecan plus 5-fluorouracil/leucovorin (mFOLFIRI) in patients with metastatic gastric adenocarcinoma refractory to or progressive after first-line chemotherapy Sun Jin Sym, Junshik Hong, Jinny Park, Cancer Chemotherapy and Pharmacology OncologyGastrointestinal OncologyMedicineBiweekly Irinotecan MonotherapyMetronomic Therapy	2012	80
Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs) Sun Jin Sym, Min‐Hee Ryu, Jae‐Lyun Lee, Journal of Surgical Oncology	2008	73
Neoadjuvant Docetaxel, Capecitabine and Cisplatin (DXP) in Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer Sun Jin Sym, Heung Moon Chang, Min‐Hee Ryu, Annals of Surgical Oncology Surgical OncologyOncologyGastrointestinal OncologyGastroenterologyPathology	2009	60

Page 1